Publications
- Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Third Faculty of Medicine, First Faculty of Medicine
- Is breastfeeding in MS harmful or not? An answer from real-world Czech data2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Third Faculty of Medicine, First Faculty of Medicine
- Assessment of Functional Capacity of Immune System in Patients with Multiple Sclerosis using QuantiFERON Monitor2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Interferon beta-1a vs. glatiramer acetate: changes of innate immunity in a group of women with multiple sclerosis2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry2022 | Faculty of Medicine in Pilsen, Second Faculty of Medicine, Third Faculty of Medicine
- Long-term efficacy and safety of ofatumumab in the treatment of multiple sclerosis2022 | Faculty of Medicine in Pilsen
- Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS2021 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Third Faculty of Medicine
- Oral cladribine in the treatment of multiple sclerosis - data from the national registry ReMuS(R) registry2021 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, First Faculty of Medicine
- An observational study demonstrating the adherence and ease of use of the injector device, RebiSmart (R)2020 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Long-term safety of ocrelizumab in the treatment of multiple sclerosis2020 | Faculty of Medicine in Pilsen
Loading network view...